Ambee Pharmaceuticals (DHA:AMBEEPHA) Total Operating Expense: BDT0.00 Mil (TTM As of . 20)


DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT764.40
View Full Analysis

What is Ambee Pharmaceuticals Total Operating Expense?

Ambee Pharmaceuticals DHA:AMBEEPHA -1.76% 18 Total Operating Expense is BDT0.00 Mil as of . 20. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Ambee Pharmaceuticals's Total Operating Expense for the six months ended in . 20 was BDT0.00 Mil. Ambee Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals Total Operating Expense Related Terms

Ambee Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Total Operating Expense Chart

Ambee Pharmaceuticals Annual Data
Trend
Total Operating Expense

Ambee Pharmaceuticals Semi-Annual Data
Total Operating Expense
DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of BDT0.00 Mil mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Total Operating Expense of BDT0.00 Mil as of . 20. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' Total Operating Expense too high?
Ambee Pharmaceuticals' current Total Operating Expense is BDT0.00 Mil. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Total Operating Expense compare to IMNPQ?
Ambee Pharmaceuticals' Total Operating Expense of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Total Operating Expense is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Total Operating Expense of BDT0.00 Mil. The current Total Operating Expense is BDT0.00 Mil. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Total Operating Expense is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT764.40
Price